Acute Effects of Cafestol on Glucose Metabolism in Subjects With Type-2-diabetes.
NCT ID: NCT04908904
Last Updated: 2022-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2021-05-27
2022-02-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Metabolic Effects of Cafestol
NCT05672433
Glucose Response in Persons with Type 2 Diabetes
NCT04914559
Glycemic Response in Persons With Type 2 Diabetes Mellitus
NCT04168541
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
NCT02856516
The Acute Effects of Coffee on Glucose Metabolism
NCT00950898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cafestol
12 mg cafestol
Cafestol
Capsule with 12 mg cafestol
Placebo
Placebo
Placebo
Placebo capsule without cafestol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cafestol
Capsule with 12 mg cafestol
Placebo
Placebo capsule without cafestol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1c ≥48 mmol/mol unless successfully treated with antidiabetic drugs and/or diet/exercise intervention
Exclusion Criteria
* Pregnancy
* Planned pregnancy
* Breastfeeding
* Significant comorbidity expected to unable the subject from completing visits
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Steno Diabetes Center Aarhus
Aarhus, Aarhus N, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cafestol.acute.t2d
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.